Using several comparative models, a new study led by MIT researchers reveals that China’s pledge to peak its carbon emissions by 2030 could cut down on as many as 160,000 premature deaths. “Politically, the research confirms why Chinese officials have their own internal reasons to cut CO2 even though the U.S. is abandoning Paris and disengaging internationally on climate,” writes Ben Geman for Axios.
A new study finds that a 4% reduction in China's carbon emissions by 2030 could save a total of $464.5 billion in healthcare costs, writes Chase Purdy for Quartz. “We have all these policy goals for a transition toward a more sustainable society,” says Associate Prof. Noelle Selin. “Mitigating air pollution, a leading cause of death, is one of them, and avoiding dangerous climate change is another.”
TechCrunch’s Devin Coldewey profiles ReviveMed, a biotech startup out of MIT that turns drug discovery into a big data problem. “ReviveMed’s approach is a fundamentally modern one that wouldn’t be possible just a few years ago, such is the scale of the data involved,” writes Coldeway.
Prof. Hugh Herr and his team in the Biomechatronics Group are developing prosthetics that “respond to neural commands with the flexibility and speed of regular limbs,” writes Eillie Anzilotti for Fast Company. In a process pioneered by the group, “doctors leave the tendons and nerve endings intact so they can continue to feed sensations down past where the human leg ends,” Anzilotti says.
James Gallagher of BBC News speaks with several experts about the microbiome and how diversity in gut bacteria is essential to health. “One thing that we're learning is, based on the microbiome, different people may need to consume different diets in order to get the same effect,” says Prof. Eric Alm.
Synlogic, founded by Prof. Jim Collins and Associate Prof. Tim Lu, is programming probiotic bacteria to treat certain genetic or acquired metabolic disease, reports Robin Seaton Jefferson for Forbes. One product is used for people whose bodies can’t maintain a healthy level of ammonia and “has been specifically engineered to convert the excess ammonia to a harmless metabolite,” explains Seaton Jefferson.
Research led by Prof. Amy Finkelstein found that just 4% of “bankruptcy filings by non-elderly adults” were associated with medical expenses. “Medical bankruptcy…wasn’t nearly as common as anticipated,” writes Alex Kingsbury for The Boston Globe. “Public policy aimed at fighting it might not have the anticipated results, either.”
A study co-authored by researchers at MIT finds that hospitalizations only cause about 4 percent of bankruptcies among nonelderly adults in the U.S., reports Tom Murphy of the Associated Press. Researchers gathered data from “more than a half million adults under 65 in California who had a hospitalization between 2003 and 2007 that wasn't tied to childbirth.”
Researchers have developed a microfluidic platform called “physiome on a chip”, which allows them to determine how certain drugs will affect up to 10 different organs. “Because the animal and human immune systems are different, [drug] testing is difficult in non-human trials,” writes Allen Cone for UPI, “but [this] system could help with that.”
Prof. Linda Griffith has created a “complex platform where researchers can put up to 10 organ tissues in separate compartments, regulating the flow of substances and medications between them in real time,” to determine how each organ will react, writes Devin Coldewey for TechCrunch. The scale of this model “represents a huge jump in the capabilities of this kind of system.”
Prof. Linda Griffith has developed ten miniature models of human organs “to create the closest we’ve come yet to a human-on-a-chip,” writes Jessica Hamzelou for New Scientist. “This is still only a minimal representation of a human,” said Griffith, but this kind of system could eventually eliminate the need for animal testing.
CBS Boston spotlights how Portal Instruments, an MIT startup, is bringing a needle-free injector to the market, which could change the way people take medicine. The device, “fires a pressurized spray to penetrate the skin, instead of piercing the skin with traditional needles.”
Boston Globe reporter Alyssa Meyers writes that a new study by MIT researchers shows that probiotics could be used to help fight high blood pressure. The researchers found that probiotics, “can boost beneficial bacteria in the human gut that prevent pro-inflammatory immune cells from increasing in number." Pro-inflammatory immune cells have been linked with hypertension.
BostInno’s Karis Hustad spotlights how Solve tackles some of the world’s most pressing challenges. “You need a different type of innovation or technology or adaptation and affordability of technology for some of the big challenges of today,” explains Alexandra Amouyel, Solve's executive director. “To do that, you need a much more bottom up, grassroots innovation process.”
This CNN video highlights tattoo ink developed by Media Lab researchers that changes colors when it detects changes in biochemistry. The researchers hope the technology could eventually be used to, “help people better monitor their health.”